Curis Provides Fourth Quarter 2024 Business Update
Provided By PR Newswire
Last update: Mar 31, 2025
FDA and EMA discussions completed to support a potential accelerated approval path in both US and EU
Orphan Drug Designation for PCNSL granted in both US and EU
Read more at prnewswire.com
